FET vs REGN · rev $816.4M vs P/E 14, rev $14.34B
Forum Energy Technologies Inc (FET) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Forum Energy Technologies Inc (FET) is a oil & gas equipment & services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FET revenue for 2024-12-31 was $816.4M. Net income was -$135.3M. Revenue was up 10.5% from 2023-12-31 to 2024-12-31. FET currently screens at market cap $257.9M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FET currently screens at market cap $257.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FET and REGN stock pages for the full models.
Not investment advice.